background image

Paid Clinical Trials Memphis

Discover 510 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

for
Metastatic Breast Cancer
Location: Memphis TN, Atlanta GA, Westwood KS, Forest City NC, Shelby NC,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 65+

Code: NCT06377852

Phase3, Recruiting
Active & Responsive

A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer
Location: Memphis TN, Westbury NY
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06624059

Phase3, Recruiting
Active & Responsive

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

for
Major Depressive Disorder
Location: Memphis TN, Atlanta GA, New Orleans LA, Edmond OK, Dallas TX,
Sponsor: Neumora Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06058013

Phase3, Recruiting
Active & Responsive

A Trial of Centanafadine Efficacy and Safety in Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety

for
ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Location: Memphis TN, Dothan AL, Jacksonville FL, San Antonio TX,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18 - 65

Code: NCT06973577

Phase3, Recruiting
Active & Responsive

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Memphis TN, St Louis MO, Atlanta GA, Cincinnati OH, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 29 - 17

Code: NCT05714085

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Active & Responsive

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

for
Age-Related Macular Degeneration
Location: Southaven MS, Nashville TN, Atlanta GA, Pensacola FL,
Sponsor: Astellas Institute for Regenerative Medicine

Sex: All

Age: 50+

Code: NCT03178149

Phase1, Recruiting
Active & Responsive

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

for
Hypertension, Hypertension, Systolic, Hypertension, Essential
Location: Germantown TN, Nashville TN, St Louis MO, Atlanta GA,
Sponsor: Orchestra BioMed, Inc

Sex: All

Age: 18+

Code: NCT06059638

Recruiting
Active & Responsive

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

for
Metastatic Breast Cancer
Location: Germantown TN, Nashville TN
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT03424005

Phase1, Phase2, Recruiting
Active & Responsive

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Germantown TN, Nashville TN, St Louis MO, Shreveport LA,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting
Active & Responsive

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Germantown TN, Hattiesburg MS, Baton Rouge LA,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting